VRTX
Vertex Pharmaceuticals Inc
508.30$
-1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 10.5% | 12.2% | 12.4% | 11.1% | 13.4% | 13.2% | 11.9% | 11.9% | 12.1% | 12.8% | 13.9% | 15.0% | |
| 89.5% | 87.8% | 87.6% | 88.9% | 86.6% | 86.8% | 88.1% | 88.1% | 87.9% | 87.2% | 86.1% | 85.0% | |
| 147.4% | 96.5% | 61.6% | 53.2% | 46.5% | 42.1% | 29.5% | 40.3% | 29.7% | 32.0% | 32.9% | 31.1% | |
| 49.8% | 34.2% | 23.6% | 19.9% | 18.3% | 15.8% | 12.4% | 11.1% | 9.9% | 11.5% | 13.3% | 14.5% | |
| 200.0% | 133.0% | 87.0% | 73.2% | 64.8% | 58.0% | 42.1% | 51.4% | 39.7% | 48.4% | 88.2% | 45.6% | |
| -119.3% | -45.4% | 0.6% | 5.0% | 20.8% | 28.8% | 46.0% | 36.7% | 48.2% | 38.8% | -2.1% | 39.4% | |
| 12.6% | 8.2% | 4.8% | 2.8% | 1.1% | 1.4% | 0.9% | 0.8% | 0.6% | 0.4% | 0.3% | 0.1% | |
| -126.6% | -54.2% | -4.0% | -0.6% | 19.7% | 33.5% | 50.2% | 36.0% | 47.4% | 44.4% | 2.3% | 38.5% | |
| 1.2% | 2.9% | 1.0% | -4.3% | -48.8% | 5.2% | 6.5% | 5.1% | 10.2% | 7.7% | 7.1% | 5.7% | |
| -127.2% | -54.1% | -6.6% | 10.6% | 68.8% | 28.3% | 43.7% | 30.9% | 37.2% | 36.7% | -4.9% | 32.7% | |
| -103.2% | -39.8% | 4.4% | 4.1% | 23.2% | 37.5% | 52.9% | 38.5% | 49.7% | 46.7% | 4.4% | 40.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.